Works about THERAPEUTIC equivalency in drugs

Results: 1061
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?

    Published in:
    Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1173, doi. 10.1007/s00280-010-1406-x
    By:
    • Mamidi, Rao N. V. S.;
    • Weng, Steve;
    • Stellar, Susan;
    • Wang, Charles;
    • Ning Yu;
    • Huang, Tony;
    • Tonelli, Alfred P.;
    • Kelley, Michael F.;
    • Angiuoli, Anthony;
    • Man-Cheong Fung
    Publication type:
    Article
    14

    Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus<sup>®</sup>) and Lantus<sup>®</sup> in healthy subjects: a double-blind, randomized clamp study.

    Published in:
    Acta Diabetologica, 2018, v. 55, n. 5, p. 461, doi. 10.1007/s00592-018-1113-3
    By:
    • Bhatia, Ashima;
    • Tawade, Shraddha;
    • Mastim, Mushtaque;
    • Kitabi, Eliford Ngaimisi;
    • Gopalakrishnan, Mathangi;
    • Shah, Manish;
    • Yeshamaina, Sridhar;
    • Gobburu, Joga;
    • Sahib, Maharaj;
    • Thakur, Dipak;
    • Prasanna Kumar, K. M.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Therapeutic Equivalence.

    Published in:
    Clinical Pediatrics, 1969, v. 8, n. 12, p. 681, doi. 10.1177/000992286900801202
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50